Literature DB >> 2569444

Unusual HLA-DR/DQ haplotypes: two different breakpoints in two different DR2-DQw3 haplotypes.

A Andreas1, D Chandanayingyong, W Attatippaholkun, M Sirikong, R Klaythong, E Keller, E D Albert.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2569444     DOI： 10.1007/BF02421546

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  14 in total

1.  Recombination between DQ alpha and DQ beta genes generates human histocompatibility leukocyte antigen class II haplotype diversity.

Authors:  Q L Song; P K Gregersen; R W Karr; J Silver
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones.

Authors:  S Rosenshine; I Cascino; A Zeevi; R J Duquesnoy; M Trucco
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Hybridization analysis reveals novel DQw3 alpha-beta associations suggesting a recombination point between DQ alpha and DQ beta on the HLA-DR4 haplotype.

Authors:  A Bushell; K J Wood; P J Morris
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Recombination sites in the HLA class II region are haplotype dependent.

Authors:  P K Gregersen; H Kao; A Nunez-Roldan; C K Hurley; R W Karr; J Silver
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

5.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

6.  Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.

Authors:  C P Liu; F H Bach; S K Wu
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

7.  HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility.

Authors:  S Scholz; E Albert
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.

Authors:  T Juji; M Satake; Y Honda; Y Doi
Journal:  Tissue Antigens       Date:  1984-11

9.  A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.

Authors:  V Lotteau; L Teyton; D Burroughs; D Charron
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

10.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598
View more
  5 in total

1.  A model for the role of HLA-DQ molecules in the pathogenesis of juvenile chronic arthritis.

Authors:  J P Haas; A Andreas; B Rutkowski; H Brunner; E Keller; J Hoza; S Havelka; G Sierp; E D Albert
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  A novel HLA-DR4 haplotype generated by a rare recombinational event between DRB1 and DQA1 loci.

Authors:  C Carcassi; R Giorda; M Trucco; L Contu
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Hypervariability of intronic simple (gt)n(ga)m repeats in HLA-DRB genes.

Authors:  O Riess; C Kammerbauer; L Roewer; V Steimle; A Andreas; E Albert; T Nagai; J T Epplen
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.

Authors:  Z T Chu; C Carswell-Crumpton; B C Cole; P P Jones
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes.

Authors:  M P Bettinotti; K Hartung; H Deicher; G Messer; E Keller; E H Weiss; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.